EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+28.55%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$833M
AUM Growth
+$833M
(+87%)
Cap. Flow
+$268M
Cap. Flow
% of AUM
32.24%
Top 10 Holdings %
Top 10 Hldgs %
55.79%
Holding
71
New
22
Increased
19
Reduced
14
Closed
11
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$58.8M |
| 2 |
AstraZeneca
AZN
|
$39.6M |
| 3 |
United Therapeutics
UTHR
|
$33M |
| 4 |
GSK
GSK
|
$32.8M |
| 5 |
Envista
NVST
|
$29.1M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$18.7M |
| 2 |
Fate Therapeutics
FATE
|
$12.3M |
| 3 |
HSKA
Heska Corp
HSKA
|
$12M |
| 4 |
OraSure Technologies
OSUR
|
$11.4M |
| 5 |
Standard BioTools
LAB
|
$9.68M |
Sector Composition
| 1 | Healthcare | 98.78% |
| 2 | Financials | 0.05% |
| 3 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
IQVIA
IQV
$31.4B
| $732K | 0.09% |
+4,085
| New | +$732K |
|
52
Agilent Technologies
A
$35.5B
| $590K | 0.07% |
+4,977
| New | +$590K |
|
53
GoHealth
GOCO
$77.4M
| $405K | 0.05% |
1,979
+1,104
| +126% | +$226K |
|
54
KalVista Pharmaceuticals
KALV
$713M
| $359K | 0.04% |
18,925
-88,375
| -82% | -$1.68M |
|
55
Zymeworks
ZYME
$1.07B
| $255K | 0.03% |
+5,405
| New | +$255K |
|
56
Merus
MRUS
$5.04B
| $253K | 0.03% |
+14,445
| New | +$253K |
|
57
Apellis Pharmaceuticals
APLS
$3.51B
| $218K | 0.03% |
3,816
-77,451
| -95% | -$4.43M |
|
58
Community Health Systems
CYH
$392M
| $95.1K | 0.01% |
+12,805
| New | +$95.1K |
|
59
Celldex Therapeutics
CLDX
$1.57B
| – | – |
-150,494
| Closed | -$2.23M |
|
60
Cytokinetics
CYTK
$5.98B
| – | – |
0
| – | – |
|
|
61
Standard BioTools
LAB
$493M
| – | – |
-1,302,353
| Closed | -$9.68M |
|
62
Liquidia Corp
LQDA
$2.52B
| – | – |
-182,751
| Closed | -$899K |
|
63
Mersana Therapeutics
MRSN
$34.8M
| – | – |
-5,600
| Closed | -$2.61M |
|
|
64
OraSure Technologies
OSUR
$230M
| – | – |
-940,412
| Closed | -$11.4M |
|
65
scPharmaceuticals
SCPH
$296M
| – | – |
-65,605
| Closed | -$489K |
|
66
Solid Biosciences
SLDB
$448M
| – | – |
-20,468
| Closed | -$623K |
|
67
Viatris
VTRS
$12.3B
| – | – |
-324,951
| Closed | -$4.82M |
|
|
MODN
68
DELISTED
MODEL N, INC.
MODN
| – | – |
-188,967
| Closed | -$6.67M |
|
|
LCI
69
DELISTED
Lannett Company, Inc.
LCI
| – | – |
0
| – | – |
|
|
TLGT
70
DELISTED
Teligent, Inc
TLGT
| – | – |
-305,423
| Closed | -$220K |
|
|
MNTA
71
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| – | – |
-98,501
| Closed | -$5.17M |
|